Mirae Asset Global Etfs Holdings Ltd. Krystal Biotech, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 12,594 shares of KRYS stock, worth $2.47 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
12,594Holding current value
$2.47 Million% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding KRYS
# of Institutions
283Shares Held
24.8MCall Options Held
270KPut Options Held
177K-
Black Rock Inc. New York, NY3.95MShares$773 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.87MShares$562 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.43MShares$477 Million6.1% of portfolio
-
State Street Corp Boston, MA1.33MShares$261 Million0.01% of portfolio
-
Redmile Group, LLC San Francisco, CA1.02MShares$200 Million12.22% of portfolio
About Krystal Biotech, Inc.
- Ticker KRYS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,664,300
- Market Cap $5.03B
- Description
- Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...